Institutional Ownership Enanta Pharmaceuticals Inc (ENTA)
This table provides information about the institutional ownership of Enanta Pharmaceuticals Inc (ENTA). We have compiled data on the 107 institutions that hold shares in the stock, with a total of 18.8 Million shares, which have been reported (via 13F filing form) to have a value of $167 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Smartleaf Asset Management LLC
Boston, MA |
Aug 14, 2025 Q2 2025 |
71
shares
|
$641
0.0% of portfolio
|
Q2 2025
Reduced 83.64%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
50
shares
|
$451
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Sep 04, 2025 Q2 2025 |
38
shares
|
$343
0.0% of portfolio
|
Q2 2025
Added 245.45%
|
|
|
Covestor LTD
Boston, MA |
Aug 11, 2025 Q2 2025 |
16
shares
|
$144
0.0% of portfolio
|
Q2 2025
Reduced 5.88%
|
|
|
Clearstead Advisors, LLC
Cleveland, OH |
Aug 08, 2025 Q2 2025 |
9
shares
|
$81
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|